Disclosure 0001610717-26-000388-1

SEC FORM 4

$550,860.80

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 29,680 shares at $18.56 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-08-25. https://desqlong.com/cards/0001610717-26-000388-1 (retrieved 2026-09-26).